Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder characterized by abdominal pain that occurs with defecation or alterations in bowel habits. Further classification is based on the predominant bowel habit: constipation-predominant IBS, diarrhea-predominant IBS (IBS-D), or mix...

Descripción completa

Detalles Bibliográficos
Autor principal: Chang, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160288/
https://www.ncbi.nlm.nih.gov/pubmed/30288076
http://dx.doi.org/10.2147/CEG.S167031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160288/
https://www.ncbi.nlm.nih.gov/pubmed/30288076
http://dx.doi.org/10.2147/CEG.S167031

Ejemplares similares